πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

7,387 results for β€œLe” Clear

  1. Levosimendan

    TENAX THERAPEUTICS, INC.

    Coronary Artery Bypass Grafting

    phase 3 small molecule completed

    1 trial

  2. Levosimendan, The levosimendan placebo drug product is an immediate-release dosage form for oral administration.

    TENAX THERAPEUTICS, INC.

    Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF)

    phase 3 small molecule active

    1 trial

  3. Levotiroxina Teva 25 microgrammi compresse

    Fondazione Telethon ETS

    Hodgkin and non Hodgkin lymphoma, Medulloblastoma

    phase 3 small molecule active

    1 trial

  4. Libmeldy 2-10 x 10^6 cells/mL dispersion for infusion

    Orchard Therapeutics (Netherlands) B.V.

    Metachromatic Leukodystrophy (MLD) is an autosomal recessive disorder caused by mutations

    phase 3 small molecule active

    1 trial

  5. Libmeldy 2-10 x 10^6 cells/mL dispersion for infusion

    Orchard Therapeutics (Netherlands) B.V.

    Metachromatic Leukodystrophy (MLD)

    phase 3 small molecule active

    1 trial

  6. Lidocaine spray

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Uterine Bleeding

    phase 3 small molecule completed

    1 trial

  7. Lifestyle modification

    Takeda

    Type 2 Diabetes

    phase 3 other completed

    1 trial

  8. Lifileucel plus Pembrolizumab

    Iovance Biotherapeutics B.V.

    Metastatic Melanoma

    phase 3 mab active

    1 trial

  9. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome Characterized by Constipation

    phase 3 small molecule completed

    1 trial

  10. Linaclotide or Matching Placebo

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome With Constipation

    phase 3 small molecule completed

    1 trial

  11. Linvoseltamab

    Regeneron UK Limited

    Relapsed and/or Refractory Multiple Myeloma (RRMM)

    phase 3 small molecule active

    1 trial

  12. Linvoseltamab

    Regeneron UK Limited

    Multiple Myeloma (MM)

    phase 3 small molecule active

    1 trial

  13. Linvoseltamab

    Regeneron UK Limited

    Relapsed Refractory Multiple Myeloma (RRMM)

    phase 3 small molecule active

    2 trials

  14. Linvoseltamab

    Regeneron UK Limited

    Multiple Myeloma

    phase 3 small molecule active

    6 trials

  15. Linvoseltamab

    Regeneron UK Limited

    High Risk Smoldering Multiple Myeloma (HR-SMM)

    phase 3 small molecule active

    1 trial

  16. Liposomal Ciclosporin A, Liposomal Ciclosporin A

    Zambon SpA

    Bronchiolitis Obliterans Syndrome in Patients post Single or post Double Lung Transplantation

    phase 3 small molecule active

    1 trial

  17. Liraglutide placebo, Saxenda 6 mg/mL solution for injection in pre-filled pen

    NovoThirteen

    Obesity

    phase 3 small molecule active

    1 trial

  18. Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immunoglobulin Light-chain Amyloidosis

    phase 3 small molecule active

    1 trial

  19. Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation Proctitis

    phase 3 small molecule active

    1 trial

  20. Locally sourced sterile 0.9% (w/v) sodium chloride, JEMPERLI 500 mg concentrate for solution for infusion

    GlaxoSmithKline

    Neoplasms, Head and Neck

    phase 3 small molecule active

    1 trial

  21. Locametz 25 micrograms kit for radiopharmaceutical preparation, ABIRATERONE , LEUPRORELIN , HISTRELIN , ENZALUTAMIDE , TRIPTORELIN , NILUTAMIDE , Pluvicto 1 000 MBq/mL solution for injection/infusion, GOSERELIN , DEGARELIX , BICALUTAMIDE , BUSERELIN , -, RELUGOLIX , APALUTAMIDE , DAROLUTAMIDE , FLUTAMIDE

    Novartis Pharmaceuticals

    PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC)

    phase 3 small molecule active

    1 trial

  22. Lokelma 5 g powder for oral suspension, Lokelma 10 g powder for oral suspension

    The George Institute

    Hyperkalemia in patients with chronic kidney disease

    phase 3 small molecule active

    1 trial

  23. Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Norditropin FlexPro, injektionsvæske, opløsning i fyldt pen, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin, Lonapegsomatropin

    Ascendis Pharma Endocrinology Division A/S

    Turner Syndrome (TS), idiopathic short stature (ISS), short stature homeobox containing gene deficiency (SHOX-D), small for gestational age (SGA)

    phase 3 small molecule active

    1 trial

  24. Lonsurf 15 mg/6.14 mg film-coated tablets, FRUZAQLA 1 mg hard capsules, Lonsurf 20 mg/8.19 mg film-coated tablets, FRUZAQLA 5 mg hard capsules

    CERO THERAPEUTICS HOLDINGS, INC.

    metastatic oeso-gastric adenocarcinoma

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources